Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study - Menzies-Gow, A; Wechsler, ME; Brightling, CE (Lancet Respir Med, 2023)
et al.